Adverse events285

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 285

Type	Event	Organ system	Group	Affected	At risk
other	Leukopenia	Blood and lymphatic system disorders	Placebo - Short Term (ST)	0	71
other	Leukopenia	Blood and lymphatic system disorders	Lulizumab Pegol 12.5 mg Weekly - ST	5	69
other	Leukopenia	Blood and lymphatic system disorders	Lulizumab Pegol 12.5 mg EOW - ST	3	68
other	Leukopenia	Blood and lymphatic system disorders	Lulizumab Pegol 5 mg EOW - ST	3	68
other	Leukopenia	Blood and lymphatic system disorders	Lulizumab Pegol 1.25 mg Every Other Week (EOW) - ST	3	70
other	Lymphopenia	Blood and lymphatic system disorders	Placebo - Short Term (ST)	0	71
other	Lymphopenia	Blood and lymphatic system disorders	Lulizumab Pegol 12.5 mg Weekly - ST	4	69
other	Lymphopenia	Blood and lymphatic system disorders	Lulizumab Pegol 12.5 mg EOW - ST	4	68
other	Lymphopenia	Blood and lymphatic system disorders	Lulizumab Pegol 5 mg EOW - ST	3	68
other	Lymphopenia	Blood and lymphatic system disorders	Lulizumab Pegol 1.25 mg Every Other Week (EOW) - ST	2	70
other	Diarrhoea	Gastrointestinal disorders	Placebo - Short Term (ST)	11	71
other	Diarrhoea	Gastrointestinal disorders	Lulizumab Pegol 12.5 mg Weekly - ST	7	69
other	Diarrhoea	Gastrointestinal disorders	Lulizumab Pegol 12.5 mg EOW - ST	1	68
other	Diarrhoea	Gastrointestinal disorders	Lulizumab Pegol 5 mg EOW - ST	5	68
other	Diarrhoea	Gastrointestinal disorders	Lulizumab Pegol 1.25 mg Every Other Week (EOW) - ST	5	70
other	Nausea	Gastrointestinal disorders	Placebo - Short Term (ST)	4	71
other	Nausea	Gastrointestinal disorders	Lulizumab Pegol 12.5 mg Weekly - ST	5	69
other	Nausea	Gastrointestinal disorders	Lulizumab Pegol 12.5 mg EOW - ST	0	68
other	Nausea	Gastrointestinal disorders	Lulizumab Pegol 5 mg EOW - ST	5	68
other	Nausea	Gastrointestinal disorders	Lulizumab Pegol 1.25 mg Every Other Week (EOW) - ST	5	70

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02265744/events

API reference For AI assistants

Adverse events285

Sources 3

Read this list from software.